CD8 T cell anti-HIV activity as a complementary protective mechanism in vaccinated chimpanzees.
Leno
M
M
Kowalski
M
M
Robert-Guroff
M
M
D016915:AIDS Vaccines / Q000276:immunology*; D000818:Animals; D016516:CD4-CD8 Ratio; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000821:virology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D015699:HIV Envelope Protein gp120 / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D019302:HIV Envelope Protein gp160 / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007117:Immunization, Secondary; D002679:Pan troglodytes; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology; D014611:Vaccination; D014779:Virus Replication
D016915:AIDS Vaccines; D015699:HIV Envelope Protein gp120; D019302:HIV Envelope Protein gp160; D011993:Recombinant Fusion Proteins